Boston Scientific announces upcoming investor conference schedule

Rhea-AI Summary

Boston Scientific (NYSE: BSX) has announced its participation in two major investor conferences in May 2025. At the Bank of America's 2025 Health Care Conference on May 13, Dan Brennan (EVP & CFO) and Joe Fitzgerald (EVP & Group President, Cardiology) will engage in a 30-minute Q&A session starting at 8:00 a.m. PT. Later, on May 28, at Bernstein's 41st Annual Strategic Decisions Conference, Chairman & CEO Mike Mahoney and Dr. Ken Stein (SVP & Global Chief Medical Officer) will participate in a 50-minute Q&A session beginning at 8:00 a.m. ET. Both events will be available via live webcast and replay on the company's investor relations website.

MARLBOROUGH, Mass., May 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May.

On May 13, 2025, Dan Brennan, executive vice president and chief financial officer, and Joe Fitzgerald, executive vice president and group president, Cardiology, will participate in a 30-minute question-and-answer session with the host analyst at Bank of America's 2025 Health Care Conference. The session will begin at approximately 8:00 a.m. PT / 11:00 a.m. ET.

On May 28, 2025, Mike Mahoney, chairman and chief executive officer, and Ken Stein, M.D., senior vice president and global chief medical officer, will participate in a 50-minute question-and-answer session with the host analyst at Bernstein's 41^st Annual Strategic Decisions Conference. The session will begin at approximately 8:00 a.m. ET.

A live webcast and replay for each event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X.  

CONTACTS:
Chanel Hastings
Media Relations
(508) 382-0288 (office)
Chanel.Hastings@bsci.com 

Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-upcoming-investor-conference-schedule-302442449.html

SOURCE Boston Scientific Corporation

FAQ

When is Boston Scientific (BSX) presenting at the Bank of America Health Care Conference 2025?

Boston Scientific will present at Bank of America's Health Care Conference on May 13, 2025, at 8:00 a.m. PT / 11:00 a.m. ET.

Who will represent BSX at Bernstein's Strategic Decisions Conference in May 2025?

Mike Mahoney (Chairman & CEO) and Ken Stein, M.D. (SVP & Global Chief Medical Officer) will represent Boston Scientific at the conference.

How can investors access Boston Scientific's conference presentations in May 2025?

Investors can access live webcasts and replays of both presentations at https://investors.bostonscientific.com.

What is the duration of BSX's Q&A session at Bernstein's conference?

Boston Scientific's Q&A session at Bernstein's conference will be 50 minutes long, starting at 8:00 a.m. ET on May 28, 2025.